A detailed history of Abrdn PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Abrdn PLC holds 800,410 shares of CDXS stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
800,410
Previous 492,648 62.47%
Holding current value
$3.11 Million
Previous $1.53 Million 61.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$2.62 - $3.71 $806,336 - $1.14 Million
307,762 Added 62.47%
800,410 $2.47 Million
Q2 2024

Aug 09, 2024

BUY
$2.65 - $3.92 $879,977 - $1.3 Million
332,067 Added 206.79%
492,648 $1.53 Million
Q4 2023

Jan 31, 2024

BUY
$1.54 - $3.37 $247,294 - $541,157
160,581 New
160,581 $489,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $254M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.